Zobrazeno 1 - 10
of 585
pro vyhledávání: '"Kazuo, Nishimura"'
Autor:
Kei Kunimasa, Naotoshi Sugimoto, Tomoyuki Yamasaki, Yoji Kukita, Fumie Fujisawa, Tazuko Inoue, Yuko Yamaguchi, Mitsuko Kitasaka, Daisuke Sakai, Keiichiro Honma, Toru Wakamatsu, Sachiko Yamamoto, Takuji Hayashi, Seiji Mabuchi, Jun Okuno, Takahisa Kawamura, Yugo Kai, Makiko Urabe, Kazuo Nishimura
Publikováno v:
Cancer Medicine, Vol 13, Iss 18, Pp n/a-n/a (2024)
Abstract Introduction Comprehensive genome profiling (CGP) has revolutionized healthcare by offering personalized medicine opportunities. However, its real‐world utility and impact remain incompletely understood. This study examined the extent to w
Externí odkaz:
https://doaj.org/article/53191da167c842a595bde87157a3ece0
Autor:
Soichiro Yoshida, Taro Takahara, Yuki Arita, Masaya Ito, Sara Hayakawa, Tomohiko Oguchi, Yoshinobu Komai, Noboru Numao, Takeshi Yuasa, Masaharu Inoue, Hiroki Ushijima, Shigehiro Kudo, Yasumasa Shimano, Yuki Nakamura, Yusuke Uchida, Sho Uehara, Hajime Tanaka, Hiroshi Yaegashi, Kouji Izumi, Minato Yokoyama, Yoh Matsuoka, Yasuo Yoshioka, Koji Konishi, Katsuyuki Nakanishi, Akira Nagahara, Akihiro Hirakawa, Ryuji Koike, Fumitaka Koga, Kazuo Nishimura, Atsushi Mizokami, Junji Yonese, Yukio Kageyama, Ryoichi Yoshimura, Yasuhisa Fujii
Publikováno v:
BMC Urology, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background The significance of metastasis-directed therapy for oligometastatic prostate cancer has been widely discussed, and targeted therapy for progressive sites is a feasible option as a multidisciplinary treatment for castration-resista
Externí odkaz:
https://doaj.org/article/a2f96538335345bc92c71087caf16814
Autor:
Yukio Kadokawa, Satoko Inoue, Akitoshi Tatsumi, Mayako Uchida, Keiko Fujita, Mari Takagi, Takako Inoue, Shuichi Ohe, Yasutomo Nakai, Tomoyuki Otsuka, Yutaro Abe, Tasuku Nakabori, Taiki Isei, Toru Kumagai, Kazuo Nishimura, Kazuyoshi Ohkawa
Publikováno v:
JGH Open, Vol 7, Iss 2, Pp 87-97 (2023)
Abstract Background and Aim To investigate the outcomes in eight Japanese patients with cancer treated with mycophenolate mofetil (MMF) and corticosteroids for immune checkpoint inhibitor treatment‐induced severe immune‐related hepatitis (ir‐he
Externí odkaz:
https://doaj.org/article/20fb7ec5c2094174a292bc9a4c635f1e
Autor:
Kazuo Nishimura, Masaki Shiota, Masatoshi Eto, Takefumi Satoh, Angela Stroupe, Caroline Seo, Alyssa Uzumcu, Dianne Athene Ledesma
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1762-1778 (2023)
Abstract Objective The study objectives were to understand how patients view the quality of life in non‐metastatic castration‐resistant prostate cancer (nmCRPC), including unmet needs and what patients consider most important in treatment outcome
Externí odkaz:
https://doaj.org/article/ae7388ed8d524f5ab7346936e1ff703e
Autor:
Kei Kunimasa, Naotoshi Sugimoto, Takahisa Kawamura, Tomoyuki Yamasaki, Keiichiro Honma, Shigenori Nagata, Yoji Kukita, Fumie Fujisawa, Tazuko Inoue, Yuko Yamaguchi, Mitsuko Kitasaka, Toru Wakamatsu, Takuo Yamai, Sachiko Yamamoto, Takuji Hayashi, Takako Inoue, Motohiro Tamiya, Fumio Imamura, Kazuo Nishimura, Kazumi Nishino
Publikováno v:
Thoracic Cancer, Vol 13, Iss 21, Pp 2970-2977 (2022)
Abstract Background The usefulness of comprehensive genomic profiling (CGP) panels for thoracic malignancies after completion of the standard treatment is unclear. Methods The results of CGP panels for malignant thoracic diseases performed at our hos
Externí odkaz:
https://doaj.org/article/5cced9d17ae34c29aad0192b84e309a7
Publikováno v:
Humanities & Social Sciences Communications, Vol 9, Iss 1, Pp 1-9 (2022)
Abstract The number of published scientific papers and patent applications are indicators of a country’s research and development (R&D) capabilities. Since the 2010s, these indicators have declined in Japan. One important reason for this decline is
Externí odkaz:
https://doaj.org/article/3f5dbb50f5a14593b3b481621c3a22f1
Autor:
Yasutomo Nakai, Tomoyuki Otsuka, Takako Inoue, Takatoshi Nawa, Koji Hatano, Yoshiyuki Yamamoto, Akira Nagahara, Masashi Nakayama, Ken‐ichi Kakimoto, Kazuo Nishimura
Publikováno v:
IJU Case Reports, Vol 4, Iss 5, Pp 326-329 (2021)
Introduction Delayed onset of immune‐related adverse events following immune‐checkpoint inhibitor discontinuation is underrecognized because of little available evidence. Case presentation A 50‐year‐old man with metastatic renal cell carcinom
Externí odkaz:
https://doaj.org/article/a8a5dce3e79a432fbbbc7938e8c7d429
Autor:
Akira Yokomizo, Hirofumi Koga, Kazuto Ito, Yutaka Takezawa, Motokiyo Komiyama, Kazuo Nishimura, Junji Yonese, Katsuyoshi Hashine, Naoya Masumori, Gaku Arai, Shiro Saito, Mitsuru Shinohara, Nobuaki Shimizu, Atsushi Yamauchi, Takefumi Satoh, Tatsuo Tochigi, Mikio Kobayashi, Hiroyuki Fujimoto, Ken‐ichi Kakimoto, Iwao Fukui, Taiji Tsukamoto, Miwako Nozaki, Katsuyuki Karasawa, Masaru Hasumi, Mikinobu Ohtani, Hiromichi Ishiyama, Masaaki Kuwahara, Masaoki Harada, Yasuo Ohashi, Toshihiko Kotake, Tadao Kakizoe, Kazuhiro Suzuki, Seiji Naito, Hidetoshi Yamanaka, National Research Project on Endocrine‐Radiation Combination Therapy for Locally Advanced Prostate Cancer investigators
Publikováno v:
Cancer Medicine, Vol 10, Iss 10, Pp 3240-3248 (2021)
Abstract Background We evaluated patient‐reported outcomes (PRO) during neoadjuvant androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) followed by either adjuvant continuous ADT (CADT) or intermittent ADT (IADT) for pati
Externí odkaz:
https://doaj.org/article/4fc6d5a819fc4ff3b13b667c17fde309
Autor:
Akinaru Yamamoto, Yasutomo Nakai, Toshiki Oka, Tomohiro Kanaki, Yoshiyuki Yamamoto, Akira Nagahara, Masashi Nakayama, Ken‐ichi Kakimoto, Kazuo Nishimura
Publikováno v:
IJU Case Reports, Vol 3, Iss 6, Pp 270-273 (2020)
Introduction Adrenocortical carcinoma is a rare malignant tumor with an unfavorable prognosis in the advanced stage for which second‐/third‐line chemotherapy is not well established. Case presentation A 34‐year‐old woman was referred to our i
Externí odkaz:
https://doaj.org/article/258d46dbf8e247f1b479fbe04d45b9ba
Autor:
Taku Yasui, Yohei Okuda, Wataru Shioyama, Toru Oka, Tatsuya Nishikawa, Risa Kamada, Koji Hatano, Kazuo Nishimura, Masashi Fujita
Publikováno v:
Cardio-Oncology, Vol 6, Iss 1, Pp 1-5 (2020)
Abstract Coronary emboli from malignant tumors rarely cause acute myocardial infarction. We report the case of a patient with tumor embolism from an upper tract urothelial carcinoma that caused acute myocardial infarction via a patent foramen ovale.
Externí odkaz:
https://doaj.org/article/3b08b79679c847b9bfcc6aa963c68001